ORCL - INFI VYNE and RSLS among premarket gainers
Context Therapeutics (NASDAQ:CNTX) +25% on positive ONA-XR data in early breast cancer study. American Virtual Cloud Technologies (NASDAQ:AVCT) +25% Kandy and Braidio announce expanded partnership to accelerate the delivery of digital transformation as a service solutions. Energy Focus (NASDAQ:EFOI) +22%. C3.ai (NYSE:AI) +18% wins $500M Department of Defense contract. VYNE Therapeutics (NASDAQ:VYNE) +14%. Oracle Corporation (NYSE:ORCL) +13% updates Q3 outlook; reiterates full-year 2022 revenue guidance. Benitec Biopharma (NASDAQ:BNTC) +12%. Infinity Pharmaceuticals (NASDAQ:INFI) +8% encouraging updated data from phase 2 MARIO-3 TNBC trial Presented at 2021 San Antonio breast cancer symposium. ReShape Lifesciences (NASDAQ:RSLS) +12%. Sprinklr (NYSE:CXM) +8% on Q3 results. Bright Health (NYSE:BHG) +8%. Longeveron (NASDAQ:LGVN) +8%. Moving iMage Technologies (NYSE:MITQ) +7%. Marpai (NASDAQ:MRAI) +7% on Q3 results. XORTX Therapeutics XRTX +6% publishes COVID-19 study in hospitalized patients at scientific journal. Broadcom (NASDAQ:AVGO) +6% on earnings beat, buyback and dividend boost. Bluejay Diagnostics (NASDAQ:BJDX) +4%.
For further details see:
INFI, VYNE and RSLS among premarket gainers